A shortage of saline for intravenous (IV) injections has been resolved, federal regulators said on Aug. 8.
The shortage of products with sodium chloride, a form of IV saline, was resolved after a joint effort involving the government and businesses, according to the Food and Drug Administration.
Companies worked to expand manufacturing while FDA officials worked to increase the amount of IV saline available to hospitals. Officials said they facilitated imports of the products and expedited reviews for American manufacturers.
“No doctor or nurse should have to deal with a drug shortage while caring for patients. We are working hard on this, and today I’m pleased to report the end of the saline shortage,” FDA Commissioner Dr. Marty Makary said in a statement….